SCHEMBL6956277

SCHEMBL6956277

O=[N+]([O-])c1c(O)nc2c(c1O)CCCCC2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 12/20 0.40
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
MAPK1 P28482 1/20 0.32
BPTF Q12830 1/20 0.32
APP P05067 1/20 0.32
BCHE P06276 1/20 0.32
CYP1A2 P05177 2/20 0.31
GAA P10253 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
USP2 O75604 1/20 0.31
HPGD P15428 2/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6701780 0.98 ACHE (0.40) ACHEKMT2AMEN1MAPK1BPTF
SCHEMBL6953068 0.73 ACHE (0.33) ACHE
SCHEMBL6948328 0.72 GRIN2D (0.40) ACHEKMT2AMEN1MAPK1APP
SCHEMBL28554918 0.68 ESR1 (0.37)
SCHEMBL7910360 0.68 PRNP (0.42) ACHEKMT2AMEN1MAPK1BCHE
SCHEMBL29606655 0.68 MAPK1 (0.41) ACHEKMT2AMEN1MAPK1BPTF
SCHEMBL2706476 0.68 MAPK1 (0.41) ACHEKMT2AMEN1MAPK1BPTF
SCHEMBL7984326 0.68 ACHE (0.32) ACHE
SCHEMBL20681024 0.66 GRIN2D (0.37) KMT2AMEN1KDM4EALDH1A1
SCHEMBL3728736 0.66 ACHE (0.39) ACHEKMT2AMEN1MAPK1BPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed